- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
AHA/ACC & ESC/EAS Lipid Guidelines: Compare & Contrast Quiz
Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.
The 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol (AHA/ACC) and the 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines for the Management of Dyslipidaemias: Lipid Modificatnion to Reduce Cardiovascular Risk (ESC/EAS) share the common goal of reducing morbidity and mortality caused by cardiovascular disease. They differ, however, in definitions of risk, particularly in what constitutes a "high-risk" patient, and also in their goals for treatment.Follwing are 4 situations, including 3 hypothetical patients, that ask you to apply your knowledge of the differences between the European and US recommendations, followed by detailed rationale for the answers.
